Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN102993142A reveals a high-yield synthesis for 4-hydroxy aurone compounds. Discover cost-effective manufacturing routes and supply chain advantages for pharmaceutical intermediates.
Patent CN101400647A details an efficient SO3-assisted nitration of isoureas, offering reduced waste acid and higher yields for reliable agrochemical intermediate supply chains.
Patent CN109721509A reveals a greener synthesis route for N-cyanoethyl ethylimidate offering substantial cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Patent CN118515585A reveals metal-free alkenyl cyanide synthesis. High yield, trans-selective. Reliable supplier for pharma intermediates.
Patent CN102267913B reveals a safer TS-1 catalyzed route for 2,3-dimethyl-2,3-dinitrobutane. Eliminate toxic nitropropane precursors for high-purity explosive tracers.
Patent CN101665811A reveals high-ee biocatalytic route for ACEI intermediates, offering superior purity and scalable production capabilities.
Patent CN101648885A reveals a novel urea-based route for Dimer Diamide. Discover cost-effective manufacturing and scalable supply chain solutions for DDI precursors.
Patent CN101045936B details a novel enzymatic resolution process using succinic anhydride, offering significant cost reduction and simplified purification for pharmaceutical intermediates.
Patent CN101955415B details a high-yield route for 2-hydroxyl biphenyl using 9-fluorenone. Discover cost-effective manufacturing and supply chain advantages.
Novel urea-based route for 1 3-adamantanediamine offers high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable supply chain reliability.
Novel MnO2/m-CPBA method for phenanthrene and biphenyl derivatives. Reduces toxicity, improves yield for pharmaceutical intermediate manufacturing.
Patent CN105503822B offers low-cost iron-catalyzed route for high-purity intermediates. Enhance supply chain reliability with scalable manufacturing.
Patent CN105503822B reveals a novel FeCl3-catalyzed synthesis for trifluoromethyl benzothiophenes, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel metal-free synthesis of ortho-haloarylamines using dihalo sulfoxide. High regioselectivity, mild conditions, ideal for reliable pharmaceutical intermediate supply chains.
Novel patent CN109836408A enables high-yield binaphthyl crown ether production. Offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN113651684B reveals a safe, scalable iron-catalyzed oxidation route for 4-hydroxy-2-butynoic acid, offering significant cost reduction in API manufacturing.
Patent CN106831675A enables green lactone production using iron catalysts. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel 5,5'-linked biphenyl ligand patent CN103524557B offers high enantioselectivity for API manufacturing and supply chain reliability for global buyers seeking partners.
Patent CN112876401A discloses a mild, one-step iridium-catalyzed synthesis of chiral 3-allylindoles with high enantioselectivity, offering cost-effective solutions for pharmaceutical manufacturing.
Patent CN107353237B reveals carbon-based catalytic route for pyrrolidone derivatives offering significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing processes.